Seismic Therapeutic
Stephanie Grebinoski is a Senior Scientist at Seismic Therapeutic since September 2022. Previously, Stephanie worked as a Scientist at the University of Pittsburgh from July 2017 to July 2022 where Stephanie was a Graduate Student Researcher studying the role of checkpoint receptors in limiting autoimmunity. Stephanie holds a PhD in Microbiology and Immunology from the University of Pittsburgh and a Bachelor's of Science in Pharmaceutical Sciences from Purdue University.
Seismic Therapeutic
1 followers
Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.